The 13th National Laboratory Medical Conference (referred to as 2017 National Laboratory Medical Conference) will be held September 20-23, 2017 in Hangzhou, Zhejiang Province by the Chinese Medical Association. The conference will cover the latest research results and trends in clinical testing and laboratory management, and it will provide a broad and comprehensive discussion of the new situation and new challenges faced by the laboratory. International and domestic first-class experts are invited to present their latest findings. The meeting will also provide educational courses, a photo exhibition, and an exhibition of latest laboratory technology. All participants will receive national medical education credits.
自 1986 年 MetaSystems 创立，本公司一直以设计生产和发展全自动显微镜成像系统为目标。MetaSystems 一贯以紧密的客户关系为重要的经营理念，在过去三十年本公司的成功全有赖于此。全赖于客户的支持，MetaSystems 一点一滴的成长，现已发展成为一个全球领先的全自动显微镜成像系统及其解决方案的供应商。
MetaSystems 全新的充满活力的现代化成像平台 Neon，可以让你轻松的管理从单一工作站到多用户、多工作站工作环境的病例、图像和结果。同时 Neon 的用户可以随时获取所有相关信息。
Detection of circulating endothelial and tumor cells
Non-hematopoietic circulating rare cells (CRCs) mainly consist of circulating tumor cells (CTCs) and circulating endothelial cells (CECs). Clinical relevance of CECs in tumor angiogenesis1 and CTCs in tumor metastasis [...] have been substantially discussed elsewhere. [...] In the present report, we extended our previous prototyping study to significantly improve the unique strength of SE-iFISH, which was developed to combine in situ phenotypic identification of tumor biomarker and karyotypic characterization of chromosome ploidy in CRCs enriched from patient biofluids (blood, bone marrow, ascites, malignant pleural effusion, and cerebrospinal fluids, etc.) [...]. [...] Metafer-iFISH®, an automated CRC scanning and image analysis system, was recently co-developed by Carl Zeiss (Oberkochen, Germany), MetaSystems (Altlussheim, Germany) and Cytelligen (San Diego, CA, USA) [...]. High through-put X-Y-Z 3-dimensional slide scanning, image acquisition, processing, classification of CRC subtypes, and statistical analyses of each subcategory of the target cells could be fully automatically performed by Metafer-iFISH upon cell size, cell cluster, quantified chromosome ploidy, and immunofluorescence staining intensity of multi-tumor biomarkers expression displayed in diverse fluorescence channels, avoiding interference from human error or bias. [...] The novel SE-iFISH provides a unique strategy for expeditious and effective enrichment, in situ phenotypic as well as karyotypic co-detection of various non-hematopoietic CRCs in cancer patients or metastatic mouse model of patient derived xenograft (mPDX)33, which allows for classification of CTCs and CECs into diverse subtypes upon biomarker expression as well as chromosome ploidy, and each subtype of CRCs may correlate with distinct clinical outcome, such as tumor angiogenesis, cancer metastasis, relapse and therapeutic drug resistance [...].
MetaSystems 的探针拥有独立的网站。如果您在寻找 MetaSystems XCyting DNA 探针，请访问 MetaSystems 探针网页。
ECA 2017 in Florence
The European Cytogeneticists Association (E.C.A) yearly meeting, the 11th European Cytogenetics Conference took place in Florence, Italy and MetaSystems was proud to be sponsor and exhibitor of this event. Visitors to the MetaSystems booth had the opportunity to see the current pre-release edition of Neon, probably the last one before the official product launch. Of course also MetaSystems Probes took the opportunity to provide cytogeneticists and other passersby to show and explain the newest probe kits and product lines. The German MetaSystems team has been actively supported by the colleagues from MetaSystems s.r.l. in Milan.
MetaSystems Indigo Exhibition on ASM 2017 in New Orleans
The growing success of microbiology related applications within the MetaSystems product portfolio led to the launch of MetaSystems Indigo, the new MetaSystems brand which unites all microbiology products under the same roof. The ASM 2017 show in New Orleans, LA (USA) has been the venue of the second MetaSystems Indigo presentation after the ECCMID 2017 in Europe.